In-silico screening of bioactive compounds of Moringa oleifera as potential inhibitors targeting HIF-1α/VEGF/GLUT-1 pathway against Breast Cancer
Journal of Complementary and Integrative Medicine,
Год журнала:
2024,
Номер
unknown
Опубликована: Июль 18, 2024
Abstract
Objectives
Breast
cancer
is
among
the
most
heterogeneous
and
aggressive
diseases
a
foremost
cause
of
death
in
women
globally.
Hypoxic
activation
HIF-1α
breast
cancers
triggers
transcription
battery
genes
encoding
proteins
that
facilitate
tumor
growth
metastasis
correlated
with
poor
prognosis.
Based
on
reported
cytotoxic
anti-cancer
properties
Moringa
oleifera
(
Mo
),
this
study
explores
inhibitory
effect
bioactive
compounds
from
M.
target
HIF-1α,
VEGF,
GLUT-1
silico
.
Methods
The
X-ray
crystallographic
structures
GLUT1
were
sourced
Protein
Data
Bank
(PDB)
docked
70
3D
PubChem
using
AutoDock
Vina,
binding
modes
analyzed
Discovery
Studio.
Five
highest
energies
selected
further
drug-likeness,
oral
bioavailability,
ADME,
toxicity
profiles
SwissADME,
ADMETSaR,
ADMETlab
3.0
web
server.
Results
Out
screened
compounds,
top
five
best
identified
namely
Apigenin,
Ellagic
Acid,
Isorhamnetin,
Luteolin,
Myricetin
each
receptor.
Molecular
docking
results
indicated
ligands
interact
strongly
receptors
through
hydrogen
bonds
hydrophobic
interactions.
These
showed
favorable
drug-like
pharmacokinetic
properties,
possessed
no
substantial
toxicity,
fairly
bioavailable.
Conclusions
suggested
possess
strong
potential
developing
putative
lead
targeting
are
safe
natural
plant-based
drugs
against
cancer.
Язык: Английский
Phytochemical Assessment and Potential Pharmacological Activity of Moringa Oleifera Extract
Aziza Alisherovna Turakhanova,
Fatima Khamzatovna Bidzhieva,
Daria Vasilyevna Solovyeva
и другие.
Pharmacophore,
Год журнала:
2024,
Номер
15(4), С. 46 - 53
Опубликована: Янв. 1, 2024
Язык: Английский
Moringa oleifera: A comprehensive review on pharmacology, phytochemistry, and clinical applications
International Journal of Pharmaceutical Chemistry and Analysis,
Год журнала:
2023,
Номер
10(4), С. 243 - 252
Опубликована: Дек. 15, 2023
commonly
referred
to
as
the
"tree
of
life"
or
"miracle
tree,"
holds
wide
spectrum
medicinal
and
non-medicinal
benefits,
so
it
is
valuable
herbal
plant.
has
been
traditionally
use
for
treating
various
disease
conditions
such
wounds,
pain,
ulcers,
liver
disease,
heart
cancer,
inflammation.
Pharmacological
studies
have
substantiated
hepatoprotective,
cardioprotective,
anti-inflammatory
potential
inherent
in
extracts
derived
from
parts
Notably,
bioactive
constituents
identified
every
part
plant,
with
over
one
hundred
compounds
characterized
date.
The
plant
rich
alkaloids,
flavonoids,
anthraquinones,
vitamins,
glycosides,
terpenes,
among
other
things.
Furthermore,
discovery
novel
chemicals
niazimin
A&B
muramoside
A&B,
revealed
potent
anticancer,
antihypertensive,
antioxidant,
nutritional
qualities.
This
current
review
underscores
traditional
remarkable
advantages
Moringa,
delving
into
its
pharmacological
characteristics,
phytopharmaceutical
formulations,
clinical
examinations,
toxicity
profile,
applications.
Additionally,
aims
shed
light
on
plant's
commercial
applications
intention
fostering
further
research.
Despite
this
comprehensive
exploration,
acknowledges
that
many
conventional
uses
Moringa
still
lack
scientific
investigation.
Consequently,
study
advocates
research
unravel
mechanistic
pathways,
aiming
pinpoint
isolate
active
synergistic
accountable
properties.
Язык: Английский